The Longevity Industry Is Selling You Anxiety
Share
And calling it wellness.
AG1 costs $79 a month. Whoop costs $239 a year. A basic Oura Ring is $299, with a $5.99 monthly subscription to understand what it's telling you. A comprehensive longevity blood panel — the kind Peter Attia recommends — runs $500 to $2,000 depending on who draws it. The eight-week sleep course is $197. The red light therapy panel is $849. The cold plunge tub starts at $4,000.
None of these products will tell you what enough looks like.
That is not an oversight. It is the business model.
The longevity industry is one of the most effective anxiety machines ever built. Not because it manufactures threats out of nothing — the body is real, aging is real, chronic disease is real — but because it takes those real facts and converts them into a permanent state of managed inadequacy.
Here is the mechanism, stated plainly:
Step one: identify a health variable most people have never measured. HRV. VO2 max. Fasting insulin. ApoB. Biological age via methylation testing.
Step two: establish a "optimal" range for that variable. Cite a study. Cite several. The studies don't need to agree; they just need to suggest that deviation from optimal is risk.
Step three: sell the product that moves the number. The supplement, the device, the program, the subscription.
Step four: introduce the next variable.
There is no step five. Step five would be: you're done, you've arrived, the numbers are good, go live your life. Step five would destroy the business.
The sophistication of this machine is that it has learned to speak in the language of science. The wellness brands of a previous era — detox teas, alkaline water, healing crystals — made claims the scientific community could easily dismiss. The longevity industry has learned to cite peer-reviewed literature, to hire researchers, to publish in legitimate journals, to have legitimate researchers on payroll.
The result is a set of products that are genuinely harder to argue with, and that therefore operate with greater confidence inside your head.
When Andrew Huberman tells you that your morning sunlight exposure is affecting your cortisol which is affecting your sleep which is affecting your testosterone which is affecting your mood and focus and productivity, he is not making it up. The links in that chain are real. But the conclusion — that you should spend an hour engineering your morning to optimize this cascade — does not follow from the science. It follows from a particular worldview: that the body is a system to be managed, and that you are its manager.
That worldview is the product. The science is the packaging.
Consider what these brands require you to believe in order to be a customer.
You must believe that your current state is suboptimal. If you were already operating at peak capacity — if the sleep was good enough, the food was fine, the body was doing what bodies do — there would be nothing to buy. The first sale is always the feeling of deficiency.
You must believe that the deficiency is specific and measurable. Not "I feel tired sometimes," which is a human condition, but "my HRV is 42 and should be 65," which is a trackable gap between your current self and a better self that costs money to reach.
You must believe that the better self is achievable and worth the cost. This is the easiest sale, because the evidence for it is unfalsifiable: you'll never know what you would have been without the stack.
The part that doesn't get examined enough is what is being displaced.
The mental energy spent monitoring, adjusting, and interpreting biomarkers is not free. The decision fatigue of a protocol-optimized day — the morning supplements, the timed eating window, the sleep hygiene checklist, the device-reviewed night — is real and cumulative. The attention required to maintain the optimization habit is attention that was previously available for other things.
What other things?
The meal you ate without checking whether it fit the protocol. The late night that went longer than was optimal for recovery. The morning you woke up and didn't look at a score before you had your first thought.
The optimization industry has been careful not to run this study. The comparison is not: optimized person vs. unoptimized person, measured by biomarkers. The comparison is: optimized person vs. person who was not managing their body as a project, measured by how they experience their life.
That study would not produce a result the industry could sell.
This is not an argument against medicine. Medicine is different. Medicine treats illness. The longevity industry treats the possibility of future illness in people who are currently healthy, and it charges for the management of that possibility indefinitely.
The difference matters. One has an endpoint — you recover, the treatment ends. The other is a subscription to the management of your own hypothetical decline, renewed monthly, with no threshold for completion.
You are not sick. You are a customer.
The optimization has no finish line. That's the product.